Read + Share
Amedeo Smart
Independent Medical Education
Yu HA, Baik C, Kim DW, Johnson ML, et al. Translational insights and overall survival in the U31402-A-U102 study of patritumab deruxtecan (HER3-DXd) in EGFR-mutated NSCLC. Ann Oncol 2024;35:437-447.PMID: 38369013
Email
LinkedIn
Facebook
Twitter
Privacy Policy